NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 175 filers reported holding NEVRO CORP in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BRAIDWELL LP | 1,192,298 | $47,215,001 | 1.58% |
Altium Capital Management LP | 76,000 | $3,009,600 | 1.53% |
Rock Springs Capital Management LP | 1,077,900 | $42,684,840 | 1.03% |
Integral Health Asset Management, LLC | 109,000 | $4,316,400 | 0.91% |
ArrowMark Colorado Holdings LLC | 1,252,218 | $49,587,833 | 0.59% |
FOX RUN MANAGEMENT, L.L.C. | 26,963 | $1,067,735 | 0.43% |
PDT Partners, LLC | 55,715 | $2,206,314 | 0.36% |
FRED ALGER MANAGEMENT, LLC | 1,184,000 | $46,886,400 | 0.25% |
Dynamic Technology Lab Private Ltd | 62,819 | $2,488 | 0.25% |
K2 PRINCIPAL FUND, L.P. | 38,000 | $1,504,800 | 0.23% |
King Wealth Management Group | 22,000 | $871 | 0.21% |
Woodline Partners LP | 318,364 | $12,607,214 | 0.17% |
K2 PRINCIPAL FUND, L.P. | 27,300 | $1,081,080 | 0.16% |
GSA CAPITAL PARTNERS LLP | 32,803 | $1,299 | 0.16% |
Bellevue Group AG | 260,835 | $10,329,066 | 0.14% |
Quantamental Technologies LLC | 6,013 | $238,115 | 0.11% |
Kula Investments, LLC | 8,889 | $352,004 | 0.10% |
Trexquant Investment LP | 88,378 | $3,499,769 | 0.10% |
Campbell & CO Investment Adviser LLC | 9,465 | $374,814 | 0.09% |
ALGERT GLOBAL LLC | 34,039 | $1,348 | 0.08% |
External links
This page lists NEVRO CORP's shareholders in Q4 2022. To view NEVRO CORP's shareholder history, click here.